A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the safety and effectiveness of ADX-N05 compared to placebo in
the treatment of excessive daytime sleepiness in adults with narcolepsy.